Regular monitoring and personalization prevent plateaus and reduce the likelihood of weight regain by addressing root causes rather than managing symptoms alone
How These Medications Work to Promote Weight Loss I work with many patients who have had great success on GLP-1s like Ozempic
As demonstrated by oxyntomodulin, a weak endogenous agonist for GLP-1 receptor and glucagon receptor, a strategy that simultaneously stimulates both GLP-1 and glucagon receptors can reduce food intake while increasing energy expenditure, synergistically enhancing weight loss [105-107]
Bridging the gap between clinical potential and real-world impact enables stakeholders to decode the complex interplay of these forces and rethink what it truly takes to keep patients on the path to sustained outcomes
These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition
Ji L, Jiang H, Cheng Z, Qiu W, Liao L, Zhang Y, et al
